Stock Events

Allogene Therapeutics (ALLO) Q1 2023 Earnings

3MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.7
-0.64
-0.58
-0.52

Details

Expected EPS
-0.62
Actual EPS
-0.68
Surprise EPS
-0.06
Surprise Percent
+9.68%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.68 per share for Q1 2023.

0 Comments

Share your thoughts